COVID-19 Neutralizing Antibody Fast Test Kit (Colloidal Gold)

Takaitaccen Bayani:

Cikakken Bayani

Nufin Amfani:

◆Domin gano ƙwayoyin rigakafi na neutralizing.

◆COVID-19 Neutralizing Antibody Rapid Test Kit (Colloidal Zinariya) Immunoassay ne na gefe yana niyya don gano ingantacciyar ƙwayar cuta ta SARS-CoV-2 a cikin jinin ɗan adam, jini ko plasma azaman taimako a cikin matakan kimantawa na rigakafin ɗan adam. -novel coronavirus neutralizing antibody titer.

Hanyar samfur

◆Dukkan Jini, Serum, Plasma

Ka'idar Aiki:

◆Wannan kit yana amfani da immunochromatography.Katin gwajin ya ƙunshi:1)colloidal-labeled zinariya recombinant novel coronavirus S-RBD antigen da ingancin kula da antibody zinariya alamomi;2) layin ganowa guda ɗaya (Layin T) da layin kulawa ɗaya mai inganci (layin C) na membrane nitrocellulose.Layin T ba shi da motsi tare da furotin ACE2 na ɗan adam don gano sabon coronavirus neutralizing antibody kuma layin C ba shi da motsi tare da ingantaccen rigakafin rigakafi.

◆Lokacin da aka ƙara adadin da ya dace na samfurin gwajin zuwa ramin samfurin katin gwajin, samfurin zai ci gaba tare da katin gwajin a ƙarƙashin aikin capillary.Idan samfurin ya ƙunshi novel coronavirus neutralizing antibody, antibody zai ɗaure ga colloidal zinariya-labeled novel coronavirus antigen.Sauran novel coronavirus antigen mai alamar zinari a cikin rukunin rigakafi za a kama su ta hanyar furotin ACE2 na ɗan adam wanda ba zai iya motsawa ba.

membrane don samar da layin T mai launin shuɗi-ja, ƙarfin t layin ya saba daidai da tattarawar antibody.

◆Katin gwajin kuma ya ƙunshi layin kula da inganci C .Ya kamata layin kula da ingancin fuchsia C ya bayyana ko da kuwa ko layin gwaji ya bayyana.Idan layin sarrafa ingancin C bai bayyana ba, sakamakon gwajin ba shi da inganci, kuma samfurin yana buƙatar sake gwadawa tare da wani katin gwaji.

Bayanin samfur:

◆Maɗaukakin ƙwayar cuta na numfashi na coronavirus 2 (SARS-CoV-2, ko 2019-nCoV) kwayar cutar RNA ce mai lullube da ba ta da tushe.Shi ne

dalilin COVID-19, wanda ke yaduwa a cikin mutane.

◆SARS-CoV-2 yana da sunadaran tsari da yawa da suka haɗa da karu (S), ambulaf (E), membrane (M) da nucleocapsid (N).Sunan furotin (S) yana ƙunshe da yanki mai ɗaure mai karɓa (RBD), wanda ke da alhakin gane mai karɓar tantanin halitta, antigens a cikin canza enzyme-2 (ACE2).Ana samun mai karɓa na ACE2 na mutum wanda ke haifar da endocytosis a cikin sel mai masaukin huhu mai zurfi da kwafi.

◆Kamuwa da cuta tare da SARS-CoV-2 ko SARS-COV-2 rigakafin rigakafi yana fara amsawar rigakafi don samar da ƙwayoyin rigakafi waɗanda ke ba da kariya daga kamuwa da cuta daga ƙwayoyin cuta na gaba.Maganin kawar da ɗan adam waɗanda ke yin niyya ga yankin mai karɓar mai karɓa na ACE2 (RBD) na furotin SAR-COV-2 yana nuna alƙawarin warkewa da inganci mai karewa.

◆Magunguna ko jini na jini/jinin yatsa.

◆Domin ganowa rabin-girma na antibody.

◆ Neutralizing antibody gwajin na iya gano ko akwai antibodies neutralizing da SARS-CoV-2 a cikin jiki.

◆Taimaka bibiyar dadewar rigakafin kariya bayan alurar riga kafi.